JPS629861B2 - - Google Patents
Info
- Publication number
- JPS629861B2 JPS629861B2 JP57005723A JP572382A JPS629861B2 JP S629861 B2 JPS629861 B2 JP S629861B2 JP 57005723 A JP57005723 A JP 57005723A JP 572382 A JP572382 A JP 572382A JP S629861 B2 JPS629861 B2 JP S629861B2
- Authority
- JP
- Japan
- Prior art keywords
- blood collection
- specific gravity
- collection tube
- fine
- blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/49—Blood
- G01N33/491—Blood by separating the blood components
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- Ecology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Centrifugal Separators (AREA)
Description
〔発明の背景〕
技術分野
この発明は血液を血液中の血清又は血漿と他の
成分とにそれぞれの比重差を利用して遠心分離す
る場合に用いられる分離用組成物を収容した採血
管に関する。
先行技術
従来、血液検査のため採血用試験管に採血した
全血を遠心分離して、血清、または血漿を血球等
から分離し、これを分析し、あるいは分析のため
輸送あるいは保存することがおこなわれる。
この場合、血清あるいは血漿の分離を確実にお
こなうため、被分離相の中間比重を有する通常バ
リヤーと称する分離用組成物を用いることが知ら
れている。
たとえば特開昭49−89389あるいは米国特許第
3780935号にはこの種分離用組成物として、シリ
コーン流体と疎水的二酸化シリコンとの混合物か
らなるゲル状材料を使用することが開示されてい
る。このゲル状材料は遠心分離時の応力によつ
て、流動性を示し、分離すべき相間に移動し、遠
心分離終了時に、分離相間に容易に破壊されるこ
とのない安定な分離層が形成される。
従来技術の問題点
しかし、このシリコーン流体とシリカ粒子との
組合せからなるゲル材料は、たとえば特開昭51−
83654に詳細に説明されているように、シリコー
ン流体がシリカ粒子表面と反応し、時間とともに
粘度が低下し、相分離した試験管から血清部分を
分取するため、管を傾けるとバリヤー層の乱血球
相の成分が血清成分に拡散し、血清の分析精度に
悪影響を及ぼすおそれがある。このことは相分離
した採血試験管の貯蔵上好ましくない。さらにこ
の種分離用組成物はシリコーン流体を主成分とし
て含むため血液凝固速度が遅く、検査時間を短縮
するために、血液凝固を促進させるための2次的
処理を必要とすること、あるいは遠心分離時、最
低1100G程度の大きな応力を要し、これは過大な
負担を与え、溶血の原因となるおそれがある。そ
のほか、遠心分離装置も必然的に高速回転可能な
高価なものを使用せざるを得ないなど種々の欠点
がある。
〔発明の目的〕
この発明は上記事情に鑑みてなされたものであ
つて、チキソトロピー性を有し、液体の遠心分離
時には容易に流動性を示し、分離相中間に移動す
るとともに、遠心分離終了時には容易に破壊され
ない安定なゲル状を保つとともに、空気中あるい
は真空中での長期保存に対しても粘度変化の影響
が少なく、かつ血液凝固の促進上も好ましい血清
又は血漿分離用組成物を収容し、栓体により減圧
状態に保持された採血管を提供することを目的と
する。
上記目的を達成するものは、開口部を有する有
底管体内にゲル化防止のための変性処理した液状
ポリブタジエン変性物を主成分とし、これに比
重、粘度調整剤およびチキソトロピー性付与のた
めの適量の構造形成剤を添加してなり真空中で実
質的に一定粘度に保持された血液から血清又は血
漿を分離するための組成物を収容し、前記有底管
体の開口部を栓体にて密封した真空採血管であ
る。
さらに、前記有底管体は底部の反対側に前記開
口部を有するものであることが好ましい。さら
に、前記液状ポリブタジエン変性物がエポキシ化
ポリブタジエンあるいはマレイン化ポリブタジエ
ンであり、比重が1.035ないし1.065の範囲である
ことが好ましい。さらに、前記比重、粘度調整剤
が微粉末シリカ、アルミナ、カーボンブラツクか
ら選ばれる無機質微粉末およびプラスチツク微粉
末から選ばれる微粉末の単独あるいは組み合わせ
であることが好ましい。さらに、前記構造形成剤
が1,3−トリメチレングリコール、1,4−ブ
タンジオール、1,5−ペンタジオール、ジエチ
レングリコール、シランカツプリング剤から選ば
れる少なくとも一種であることが好ましい。さら
に、前記分離用組成物が液状ポリブタジエン変性
物100重量部、比重、粘度調整剤として微粉末シ
リカ5〜10重量部、構造形成剤としてトリメチレ
ングリコール0.1〜2.0重量部からなり、比重が、
1.035ないし1.065の範囲であることが好ましい。
〔発明の具体的説明〕
以下、この発明を図示の実施例を参照して説明
する。
図面はこの発明に係る採血管の一実施例を示す
もので、有底管体1(10c.c.管)の底部に深さ約15
mmに血清又は血漿分離用組成物2が収容され、有
底管体1の開口部にたとえばブチルゴムからなる
栓体3が嵌挿されている。この場合、有底管体1
内部は真空化処理すなわち減圧状態に保ち採血時
の便を図るようにしてある。また、有底管体1お
よび栓体の形状は公知の形態のものを任意に採用
することができる。又、分離用組成物2の管体1
内での収容位置も管底に限らず公知の如く必要に
応じ管体上部、中間位置に保持させるようにして
もよい。
この発明において使用される血清又は血漿分離
用組成物は長期保存性の観点から、エポキシ化あ
るいはマレイン化等のゲル防止処理を施したとこ
ろに特徴がある。比重、粘度調整剤としては微粉
末シリカ、アルミナ、カーボンブラツク等の無機
質の微粉末あるいはプラスチツク微粉末たとえば
ナイロン微粉末等を単独あるいは組合せて使用す
ることができる。この比重、粘度調整剤は液状ポ
リブタジエン変性物に対し分散性がよく、遠心分
離すべき液体に対し、悪影響を与えない性質のも
のを適宜選択すればよい。
チキソトロピー性付与のための構造形成剤とし
ては1,3−トリメチレングリコール、1,4−
ブタンジオール、1,5−ペンタンジオール、ジ
エチレングリコール、シランカツプリング剤、た
とえばグリシドキシ−プロピルトリメトキシシラ
ン等のアルコキシシランである。
本発明において血清又は血漿分離用組成物は通
常比重1.035ないし1.065の範囲のものに調整され
る。この場合の組成例を下記に示す。
[Background of the Invention] Technical Field The present invention relates to a blood collection tube containing a separation composition used when centrifuging blood into serum or plasma and other components by utilizing the difference in specific gravity of each component. Prior Art Conventionally, whole blood collected in a blood collection test tube for blood testing has been centrifuged to separate serum or plasma from blood cells, etc., and this has been analyzed, or transported or stored for analysis. It can be done. In this case, in order to reliably separate serum or plasma, it is known to use a separation composition, usually called a barrier, which has a specific gravity intermediate to that of the phase to be separated. For example, Japanese Patent Application Publication No. 49-89389 or U.S. Patent No.
No. 3,780,935 discloses the use of a gel-like material consisting of a mixture of silicone fluid and hydrophobic silicon dioxide as a separation composition of this type. This gel-like material exhibits fluidity and moves between the phases to be separated due to the stress during centrifugation, and at the end of centrifugation, a stable separation layer that will not be easily destroyed is formed between the separated phases. Ru. Problems with the prior art However, gel materials made of a combination of silicone fluid and silica particles, for example,
83654, the silicone fluid reacts with the silica particle surface, its viscosity decreases over time, and the serum portion is collected from the phase-separated test tube by tilting the tube, which disturbs the barrier layer. Components of the blood cell phase may diffuse into serum components, which may adversely affect the accuracy of serum analysis. This is unfavorable in terms of storage of phase-separated blood collection test tubes. Furthermore, since this type of separation composition contains silicone fluid as its main component, the rate of blood coagulation is slow, and in order to shorten testing time, it requires secondary treatment to promote blood coagulation or centrifugation. At the same time, a large stress of at least 1100 G is required, which is an excessive burden and may cause hemolysis. In addition, there are various drawbacks, such as the necessity of using an expensive centrifugal separator that can rotate at high speed. [Object of the Invention] This invention has been made in view of the above circumstances, and has thixotropic properties, easily exhibits fluidity during centrifugation of liquid, moves to the middle of the separated phase, and at the end of centrifugation, Contains a composition for serum or plasma separation that maintains a stable gel-like state that is not easily destroyed, has little effect of viscosity change during long-term storage in air or vacuum, and is preferable for promoting blood coagulation. The object of the present invention is to provide a blood collection tube that is maintained in a reduced pressure state by a stopper. The product that achieves the above purpose consists mainly of a liquid polybutadiene modified product that has been subjected to a modification treatment to prevent gelation in a bottomed tube with an opening, and an appropriate amount of a specific gravity and viscosity modifier and a thixotropic agent to impart thixotropy. containing a composition for separating serum or plasma from blood which is maintained at a substantially constant viscosity in vacuum by adding a structure-forming agent, and the opening of the bottomed tube is closed with a stopper. It is a sealed vacuum blood collection tube. Furthermore, it is preferable that the bottomed tube has the opening on the opposite side of the bottom. Furthermore, it is preferable that the liquid polybutadiene modified product is epoxidized polybutadiene or maleated polybutadiene, and has a specific gravity in the range of 1.035 to 1.065. Furthermore, it is preferable that the specific gravity and viscosity modifier is a fine inorganic powder selected from fine silica, alumina, and carbon black, and a fine powder selected from fine plastic powder, either alone or in combination. Furthermore, it is preferable that the structure forming agent is at least one selected from 1,3-trimethylene glycol, 1,4-butanediol, 1,5-pentadiol, diethylene glycol, and a silane coupling agent. Furthermore, the separation composition comprises 100 parts by weight of a liquid polybutadiene modified material, 5 to 10 parts by weight of finely powdered silica as a specific gravity and viscosity modifier, and 0.1 to 2.0 parts by weight of trimethylene glycol as a structure forming agent, and has a specific gravity of
It is preferably in the range of 1.035 to 1.065. [Specific Description of the Invention] The present invention will be described below with reference to illustrated embodiments. The drawing shows an embodiment of the blood collection tube according to the present invention, in which the bottom of the bottomed tube body 1 (10 c.c. tube) has a depth of approximately 15 mm.
A serum or plasma separation composition 2 is contained in the tube 1, and a stopper 3 made of, for example, butyl rubber is fitted into the opening of the bottomed tube 1. In this case, the bottomed tube body 1
The interior is kept in a vacuum state, that is, under reduced pressure, to facilitate drainage during blood collection. Furthermore, the shapes of the bottomed tube body 1 and the plug body can be arbitrarily selected from known shapes. Moreover, the tube body 1 of the separation composition 2
The storage position within the tube is not limited to the bottom of the tube, but as is well known, it may be held at the upper part of the tube or at an intermediate position as required. The composition for serum or plasma separation used in this invention is characterized by being subjected to gel-preventing treatment such as epoxidation or maleation from the viewpoint of long-term storage. As specific gravity and viscosity modifiers, inorganic fine powders such as finely divided silica, alumina, and carbon black, or fine plastic powders such as fine nylon powders can be used alone or in combination. The specific gravity and viscosity modifier may be appropriately selected from those that have good dispersibility in the liquid modified polybutadiene and do not have any adverse effect on the liquid to be centrifuged. Structure-forming agents for imparting thixotropy include 1,3-trimethylene glycol, 1,4-
butanediol, 1,5-pentanediol, diethylene glycol, silane coupling agents such as alkoxysilanes such as glycidoxy-propyltrimethoxysilane. In the present invention, the composition for serum or plasma separation is usually adjusted to have a specific gravity in the range of 1.035 to 1.065. A composition example in this case is shown below.
【表】
この発明において、血清又は血漿分離用組成物
は真空中に保存しておき、必要に応じて有底管体
内に予め適量分注したのち、真空化工程によつて
脱泡をおこない、しかるのち該管を栓体により密
封し、真空採血管として使用する。
実施例
エポキシ化シスブタジエン(比重d241.019、粘
度4500CP/20℃)100重量部とアエロジル(商品
名、日本アエロジル社製の疎水性シリカ微粉末比
重2.2)5.5重量部と、トリメチレングリコール0.2
重量部とを混合し、比重約1.048、粘度約150万
CP(20℃)のチキソトロピー性物質を得た。つ
いでこれを空気中あるいは真空中に保存して、ま
た、比較例として同様のチキソトロピー性物質を
空気中に保存して同様にその粘度変化を測定し
た。
その結果は下記に示すとおりであつた。[Table] In this invention, the composition for serum or plasma separation is stored in a vacuum, and if necessary, an appropriate amount is dispensed into a bottomed tube in advance, and then defoamed by a vacuuming step. The tube is then sealed with a stopper and used as a vacuum blood collection tube. Example 100 parts by weight of epoxidized cis-butadiene (specific gravity d 24 1.019, viscosity 4500CP/20°C), 5.5 parts by weight of Aerosil (trade name, hydrophobic silica fine powder specific gravity 2.2 manufactured by Nippon Aerosil Co., Ltd.), and 0.2 parts by weight of trimethylene glycol
Mix parts by weight, specific gravity approximately 1.048, viscosity approximately 1.5 million
A thixotropic substance of CP (20°C) was obtained. This was then stored in air or vacuum, and as a comparative example, a similar thixotropic substance was stored in air and its viscosity change was measured in the same manner. The results were as shown below.
【表】
この表2からチキソトロピー性物質は空気中で
は従来技術とは逆に粘度が上がり、真空中では粘
度変化がほとんど起こらないことがわかつた。
ついで、この組成物2c.c.を、直径12mm、容積10
c.c.の採血用試験管に分注し、ついで真空化処理す
なわち減圧化状態に保ち、栓体で密封して採血時
の便を図るようにしたのち、この試験管を用いて
採血をおこなつた。これを遠心分離(2500r.p.m.
、10分間、腕長約10cm)した結果、本発明の実施
例では血清と血球との間に厚さ約2cmの円板状バ
リヤー層が形成された。このバリヤー層は数十日
間放置しても、また振動等の衝撃を与えても全く
破壊されず、安定した非流動状態を保ち得ること
が確認された。なお、この実施例において、エポ
キシ化シスブタジエンの代りにマレイン化シスポ
リブタジエン(比重d241.016、粘度4500CP/20
℃)を使用した以外は同様に実施した結果、エポ
キシ化シスブタジエンを用いた場合とほぼ同様の
結果が得られた。
以上、詳述したように、この血清または血漿分
離用組成物は予め真空中に保存することによつて
安定したチキソトロピー性を有するから、遠心分
離によつて形成されるバリヤー層は容易に破壊さ
れず、デカンテーシヨンによつて簡単に分離層を
分取することができるから、血清分離等において
もその収量も増大が図れるとともに、真空中にお
いても粘度変化が少なく分離層の長期間の保存も
可能である。さらに、チキソトロピー指数が比較
的大きいため、遠心分離時の応力も700G程度で
十分であるから血球の破壊等のおそれもないなど
使用上極めて有利である。[Table] From Table 2, it was found that the viscosity of thixotropic substances increases in air, contrary to the prior art, and that almost no viscosity change occurs in vacuum. Next, add 2 c.c. of this composition to a container with a diameter of 12 mm and a volume of 10
The sample was dispensed into a cc blood collection test tube, which was then vacuumed, that is, kept under reduced pressure, and sealed with a stopper to allow for drainage during blood collection.The blood was then collected using this test tube. . This is centrifuged (2500r.pm)
, for 10 minutes, arm length approximately 10 cm), and as a result, in the example of the present invention, a disc-shaped barrier layer with a thickness of approximately 2 cm was formed between the serum and blood cells. It was confirmed that this barrier layer was not destroyed at all even when left for several tens of days or when subjected to shocks such as vibrations, and could maintain a stable non-fluid state. In this example, maleated cis-polybutadiene (specific gravity d 24 1.016, viscosity 4500CP/20
As a result of carrying out the same procedure except that epoxidized cis-butadiene was used, almost the same results were obtained as when using epoxidized cis-butadiene. As detailed above, since this composition for serum or plasma separation has stable thixotropic properties by being stored in vacuum in advance, the barrier layer formed by centrifugation is easily destroyed. Since the separated layer can be easily separated by decantation, the yield can be increased in serum separation, etc., and the viscosity does not change even in vacuum, making it possible to store the separated layer for a long time. It is possible. Furthermore, since the thixotropic index is relatively large, the stress during centrifugation of about 700 G is sufficient, so there is no risk of destruction of blood cells, etc., making it extremely advantageous in use.
図面は本発明に係わる採血管の一実施例を示す
断面図である。
1…有底管体、2…血清又は血漿分離用組成
物、3…栓体。
The drawing is a sectional view showing one embodiment of a blood collection tube according to the present invention. 1... Bottomed tube body, 2... Serum or plasma separation composition, 3... Stopper body.
Claims (1)
めの変性処理した液状ポリブタジエン変性物を主
成分とし、これに比重、粘度調整剤およびチキソ
トロピー性付与のための適量の構造形成剤を添加
してなり真空中で実質的に一定粘度に保持された
血液から血清又は血漿を分離するための組成物を
収容し、前記有底管体の開口部を栓体にて密封し
たことを特徴とする真空採血管。 2 前記有底管体は、底部の反対側に前記開口部
を有するものである特許請求の範囲第1項に記載
の採血管。 3 前記液状ポリブタジエン変性物がエポキシ化
ポリブタジエンあるいはマレイン化ポリブタジエ
ンであり、比重が1.035ないし1.065の範囲である
特許請求の範囲第1項または第2項に記載の採血
管。 4 前記比重、粘度調整剤が、微粉末シリカ、ア
ルミナ、カーボンブラツクから選ばれる無機質微
粉末およびプラスチツク微粉末から選ばれる微粉
末の単独あるいは組み合わせである特許請求の範
囲第3項に記載の採血管。 5 前記構造形成剤が、1,3−トリメチレング
リコール、1,4−ブタンジオール、1,5−ペ
ンタジオール、ジエチレングリコール、シランカ
ツプリング剤から選ばれる少なくとも一種である
特許請求の範囲第3項に記載の採血管。 6 前記分離用組成物が、液状ポリブタジエン変
性物100重量部、比重、粘度調整剤として微粉末
シリカ5〜10重量部、構造形成剤としてトリメチ
レングリコール0.1〜2.0重量部からなり、比重
が、1.035ないし1.065の範囲である特許請求の範
囲第1項または第2項に記載の採血管。[Scope of Claims] 1 A bottomed tube having an opening contains a liquid polybutadiene modified product which has been subjected to a modification treatment to prevent gelation as a main component, and contains an appropriate amount of a specific gravity and viscosity modifier and a thixotropic property. Contains a composition for separating serum or plasma from blood that is maintained at a substantially constant viscosity in vacuum by adding a structure-forming agent, and seals the opening of the bottomed tube body with a stopper. A vacuum blood collection tube characterized by: 2. The blood collection tube according to claim 1, wherein the bottomed tube has the opening on the opposite side of the bottom. 3. The blood collection tube according to claim 1 or 2, wherein the liquid polybutadiene modified product is epoxidized polybutadiene or maleated polybutadiene, and has a specific gravity in the range of 1.035 to 1.065. 4. The blood collection tube according to claim 3, wherein the specific gravity and viscosity modifier is a fine inorganic powder selected from fine silica, alumina, and carbon black, and a fine powder selected from fine plastic powder, either alone or in combination. . 5. Claim 3, wherein the structure forming agent is at least one selected from 1,3-trimethylene glycol, 1,4-butanediol, 1,5-pentadiol, diethylene glycol, and a silane coupling agent. Blood collection tube as described. 6 The separation composition consists of 100 parts by weight of a liquid polybutadiene modified material, 5 to 10 parts by weight of finely powdered silica as a specific gravity and viscosity modifier, and 0.1 to 2.0 parts by weight of trimethylene glycol as a structure forming agent, and has a specific gravity of 1.035. 2. The blood collection tube according to claim 1 or 2, wherein the blood collection tube is in the range of 1.065 to 1.065.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP572382A JPS57141558A (en) | 1982-01-18 | 1982-01-18 | Blood collecting tube |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP572382A JPS57141558A (en) | 1982-01-18 | 1982-01-18 | Blood collecting tube |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP12668876A Division JPS5351189A (en) | 1976-10-21 | 1976-10-21 | Composite for liquid separation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS57141558A JPS57141558A (en) | 1982-09-01 |
| JPS629861B2 true JPS629861B2 (en) | 1987-03-03 |
Family
ID=11619033
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP572382A Granted JPS57141558A (en) | 1982-01-18 | 1982-01-18 | Blood collecting tube |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS57141558A (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0677014B2 (en) * | 1987-08-14 | 1994-09-28 | テルモ株式会社 | Blood separation tube |
| US4994393A (en) * | 1989-02-22 | 1991-02-19 | Becton, Dickinson And Company | Blood partitioning composition |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3852194A (en) * | 1972-12-11 | 1974-12-03 | Corning Glass Works | Apparatus and method for fluid collection and partitioning |
| US4049692A (en) * | 1974-12-16 | 1977-09-20 | Corning Glass Works | Stabilized blood separating composition |
| JPS51126688A (en) * | 1975-04-24 | 1976-11-04 | Hitachi Zosen Corp | Connecting device of pusher and purge |
| JPS5351189A (en) * | 1976-10-21 | 1978-05-10 | Terumo Corp | Composite for liquid separation |
-
1982
- 1982-01-18 JP JP572382A patent/JPS57141558A/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS57141558A (en) | 1982-09-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4350593A (en) | Assembly, compositions and method for separating blood | |
| KR930011033B1 (en) | Vacuum blood collection tube | |
| US4917801A (en) | Lymphocyte collection tube | |
| US3852194A (en) | Apparatus and method for fluid collection and partitioning | |
| US4172803A (en) | Liquid separating composition and apparatus for applying said composition | |
| US3920549A (en) | Method and apparatus for multiphase fluid collection and separation | |
| US5053134A (en) | Lymphocyte collection tube | |
| US5632905A (en) | Method and apparatus for separating formed and unformed components | |
| US4770779A (en) | Apparatus for separating blood | |
| EP0035575B1 (en) | Blood serum-separating agent | |
| JP5297191B2 (en) | Serum or plasma separation composition and blood test container | |
| AU2015347309B2 (en) | Mechanical separator for a biological fluid | |
| US20130259771A1 (en) | High Bias Gel Tube and Process for Making Tube | |
| US4180465A (en) | Fluid collection device with phase separation means | |
| US4707276A (en) | Fluid collection device with phase partitioning means | |
| CA1041903A (en) | Blood coagulation and separation | |
| WO1996024058A1 (en) | Component separation member and component separator equipped with said member | |
| JPH05107245A (en) | Blood separator | |
| CA1291098C (en) | Lymphocyte collection tube | |
| JPS629861B2 (en) | ||
| JP7601359B2 (en) | Blood collection container, plasma separation method, extracellular free nucleic acid separation method, and extracellular vesicle separation method | |
| US3986962A (en) | Novel assembly for separating blood | |
| JPH0743369B2 (en) | Composition for separating serum or plasma | |
| JPH08201380A (en) | Blood separation member and blood separation/collection tube with it | |
| JP2001269328A (en) | Blood collection tube |